Dr. Reddy's Laboratories Limited (RDY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Dr. Reddy's Laboratories ...

    NYSE: RDY · Real-Time Price · USD
    14.18
    0.12 (0.82%)
    At close: Oct 03, 2025, 3:59 PM
    14.16
    -0.11%
    After-hours: Oct 03, 2025, 05:16 PM EDT

    Dr. Reddy's Laboratories Balance Sheet Statement

    Financials in INR. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 14.65B 7.11B 5.78B 14.85B 14.83B
    Short-Term Investments
    		 43.25B 74.36B 60.97B 29.51B 19.74B
    Long-Term Investments
    		 15.2B 5.25B 6.09B 7.99B 8.33B
    Other Long-Term Assets
    		 2.79B 16.12B 12.71B 948M 952M
    Receivables
    		 109.79B 95.34B 72.48B 80.27B 58.94B
    Inventory
    		 71.08B 63.55B 48.67B 50.88B 45.41B
    Other Current Assets
    		 4.56B 20.78B 19.85B 18.7B 17.48B
    Total Current Assets
    		 250.11B 248.05B 204.25B 181.11B 148.25B
    Property-Plant & Equipment
    		 97.76B 76.89B 56.54B 62.17B 57.11B
    Goodwill & Intangibles
    		 108.61B 41.2B 36.2B 31.66B 40.22B
    Total Long-Term Assets
    		 242.88B 139.47B 118.6B 115.55B 117.24B
    Total Assets
    		 492.99B 387.52B 322.85B 296.65B 265.49B
    Account Payables
    		 20.05B 21.55B 17.86B 15.97B 12.7B
    Deferred Revenue
    		 1.98B n/a 1.98B 2.58B 2.03B
    Short-Term Debt
    		 38.05B 12.72B 11.19B 27.08B 23.14B
    Other Current Liabilities
    		 13.52B 19.97B 16.95B 17.69B 14.88B
    Total Current Liabilities
    		 130.39B 96.04B 85.72B 97.84B 81.47B
    Long-Term Debt
    		 3.8B 3.8B n/a 3.8B 3.8B
    Other Long-Term Liabilities
    		 2.3B 4.94B 2.99B 2.54B 2.4B
    Total Long-Term Liabilities
    		 25.43B 10.93B 4.27B 8.29B 9.04B
    Total Liabilities
    		 155.82B 106.97B 89.99B 106.13B 90.51B
    Total Debt
    		 46.77B 20.02B 13.47B 33.84B 30.31B
    Book Value
    		 337.17B 280.55B 232.86B 190.53B 174.98B
    Book Value Per Share
    		 404.61 336.58 280.50 229.71 211.02
    Common Stock
    		 834M 834M 833M 832M 832M
    Retained Earnings
    		 315.79B 265.26B 215.59B 175.71B 157.93B
    Comprehensive Income
    		 3.98B 4.03B 1.27B 1.06B 1.33B
    Shareholders Equity
    		 333.39B 280.55B 232.86B 190.53B 174.98B
    Total Investments
    		 58.46B 79.62B 67.06B 37.5B 28.08B

    Add to Watchlist